CD8A and breast carcinoma: We applied the TIMER tool to investigate tumor purity and the infiltrating immune cell landscape of breast cancer (B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages and dendritic cells) in the context of mRNA expression of our target genes (Figure 7, Table 4, Supplementary Table 1).